C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) A61P 11/06 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2447765
Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are phosphodiesterase-4 inhibitors useful in the treatment of asthma and inflammation.
L'invention concerne des composés représentés par la formule (I) ou un sel pharmaceutiquement acceptable de ceux-ci, ces composés étant des inhibiteurs de phosphodiestérase-4 utiles dans le traitement de l'asthme et d'inflammation.
Friesen Richard
Girard Mario
Girard Yves
Guay Daniel
Hamel Pierre
Merck Frosst Canada & Co./merck Frosst Canada & Cie
Merck Frosst Canada Ltd.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1570656